Recent Posts
- Voyager’s tau-reducing therapies show promise in preclinical studies March 28, 2024
- Being someone’s sole caregiver doesn’t mean you’re alone March 25, 2024
- FDA advisory committee to review donanemab for early Alzheimer’s March 21, 2024
- Alzheimer’s blood test gets FDA breakthrough device designation March 14, 2024
- AR1001 Phase 3 trial in early Alzheimer’s to begin recruiting in UK March 7, 2024